258 related articles for article (PubMed ID: 8441243)
1. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases.
van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Weening JJ; Berden JH
Kidney Int; 1993 Feb; 43(2):454-63. PubMed ID: 8441243
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues.
van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Berden JH
J Histochem Cytochem; 1994 Jan; 42(1):89-102. PubMed ID: 8263327
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats.
van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Berden JH
Kidney Int; 1992 Jan; 41(1):115-23. PubMed ID: 1593846
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the extracellular matrix components in human glomerular diseases.
Oomura A; Nakamura T; Arakawa M; Ooshima A; Isemura M
Virchows Arch A Pathol Anat Histopathol; 1989; 415(2):151-9. PubMed ID: 2500770
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate.
van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Berden JH
Lab Invest; 1991 Sep; 65(3):287-97. PubMed ID: 1890809
[TBL] [Abstract][Full Text] [Related]
6. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.
Tamsma JT; van den Born J; Bruijn JA; Assmann KJ; Weening JJ; Berden JH; Wieslander J; Schrama E; Hermans J; Veerkamp JH
Diabetologia; 1994 Mar; 37(3):313-20. PubMed ID: 8174847
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to heparan sulfate proteoglycan: development and application to the study of normal tissue and pathologic human kidney biopsies.
Kemeny E; Fillit HM; Damle S; Mahabir R; Kefalides NA; Gregory JD; Antonovych T; Sabnis S; Zabriskie JB
Connect Tissue Res; 1988; 18(1):9-25. PubMed ID: 2972530
[TBL] [Abstract][Full Text] [Related]
8. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
Raats CJ; Van Den Born J; Berden JH
Kidney Int; 2000 Feb; 57(2):385-400. PubMed ID: 10652015
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening.
Miettinen A; Stow JL; Mentone S; Farquhar MG
J Exp Med; 1986 May; 163(5):1064-84. PubMed ID: 2939168
[TBL] [Abstract][Full Text] [Related]
10. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.
van Det NF; van den Born J; Tamsma JT; Verhagen NA; van den Heuvel LP; Berden JH; Bruijn JA; Daha MR; van der Woude FJ
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):759-68. PubMed ID: 7537959
[TBL] [Abstract][Full Text] [Related]
11. Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane.
Groffen AJ; Ruegg MA; Dijkman H; van de Velden TJ; Buskens CA; van den Born J; Assmann KJ; Monnens LA; Veerkamp JH; van den Heuvel LP
J Histochem Cytochem; 1998 Jan; 46(1):19-27. PubMed ID: 9405491
[TBL] [Abstract][Full Text] [Related]
12. Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis.
Kim HJ; Hong YH; Kim YJ; Kim HS; Park JW; Do JY; Kim KJ; Bae SW; Kim CW; Lee CK
Lupus; 2017 Jul; 26(8):815-824. PubMed ID: 28420046
[TBL] [Abstract][Full Text] [Related]
13. Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium.
Yard BA; Kahlert S; Engelleiter R; Resch S; Waldherr R; Groffen AJ; van den Heuvel LP; van der Born J; Berden JH; Kröger S; Hafner M; van der Woude FJ
Exp Nephrol; 2001; 9(3):214-22. PubMed ID: 11340306
[TBL] [Abstract][Full Text] [Related]
14. Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosus.
Seyger MM; van Bruggen MC; Hardeman HK; van den Hoogen FH; Berden JH; van den Born J; De Jong EM
Acta Derm Venereol; 1998 Sep; 78(5):326-30. PubMed ID: 9779246
[TBL] [Abstract][Full Text] [Related]
15. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells.
Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
Am J Physiol; 1988 Oct; 255(4 Pt 2):F590-6. PubMed ID: 2972214
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus.
Vernier RL; Steffes MW; Sisson-Ross S; Mauer SM
Kidney Int; 1992 Apr; 41(4):1070-80. PubMed ID: 1513088
[TBL] [Abstract][Full Text] [Related]
17. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis.
van Bruggen MC; Kramers K; Hylkema MN; van den Born J; Bakker MA; Assmann KJ; Smeenk RJ; Berden JH
Am J Pathol; 1995 Mar; 146(3):753-63. PubMed ID: 7534044
[TBL] [Abstract][Full Text] [Related]
18. Anionic site and immunogold quantitation of heparan sulfate proteoglycans in glomerular basement membranes of puromycin aminonucleoside nephrotic rats.
Rada JA; Carlson EC
Anat Rec; 1991 Sep; 231(1):35-47. PubMed ID: 1750710
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the existence of multiple heparan sulfate proteoglycans in the human glomerular basement membrane and mesangial matrix.
Groffen AJ; Hop FW; Tryggvason K; Dijkman H; Assmann KJ; Veerkamp JH; Monnens LA; Van den Heuvel LP
Eur J Biochem; 1997 Jul; 247(1):175-82. PubMed ID: 9249024
[TBL] [Abstract][Full Text] [Related]
20. [Heparan sulfate proteoglycan distribution in the glomerular basal membrane in human glomerulonephritis].
Kemény E; Fillit MH; Mahabir R; Zabriskie BJ
Morphol Igazsagugyi Orv Sz; 1989 Oct; 29(4):287-91. PubMed ID: 2531843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
